Literature DB >> 3312495

Amyloid angiopathy of Alzheimer's disease: amino acid composition and partial sequence of a 4,200-dalton peptide isolated from cortical microvessels.

W M Pardridge1, H V Vinters, J Yang, J Eisenberg, T B Choi, W W Tourtellotte, V Huebner, J E Shively.   

Abstract

The cardinal lesions of Alzheimer's disease are neurofibrillary tangles, senile neuritic plaques, and vascular amyloid, the latter generally involving cortical arteries and small arterioles. All three lesions are composed of amyloid-like, beta-pleated sheet fibrils. Recently, a 4,200-dalton peptide has been isolated from extraparenchymal meningeal vessels, neuritic plaques, and neurofibrillary tangles. The assumption of N-terminal homogeneity in vascular amyloid has been used as an argument for a neuronal (versus blood) origin of the peptide. However, intracortical microvessels from Alzheimer's disease have not been previously isolated. The present studies describe the isolation of a microvessel fraction from Alzheimer's disease and control fresh autopsy human brain. Alzheimer's disease isolated brain microvessels that were extensively laden with amyloid and control microvessels were solubilized in 90% formic acid and analyzed by urea sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The arteriole fraction from the Alzheimer's subject with extensive amyloid angiopathy contained a unique 4,200-dalton peptide, whereas the arterioles or capillaries isolated from two controls and two Alzheimer's disease subjects without angiopathy did not. This peptide was purified by HPLC and amino acid composition analysis showed the peptide is nearly identical to the 4,200-dalton peptide recently isolated from neuritic plaques or from neurofibrillary tangles. Sequence analysis revealed N-terminal heterogeneity. The N-terminal sequence was: Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr, which is identical to the N-terminal sequence of the 4,200-dalton peptide isolated previously from extraparenchymal meningeal vessels and neuritic plaques.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3312495     DOI: 10.1111/j.1471-4159.1987.tb01005.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  16 in total

1.  Immunoreactive A4 and gamma-trace peptide colocalization in amyloidotic arteriolar lesions in brains of patients with Alzheimer's disease.

Authors:  H V Vinters; G S Nishimura; D L Secor; W M Pardridge
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

2.  Drug targeting of a peptide radiopharmaceutical through the primate blood-brain barrier in vivo with a monoclonal antibody to the human insulin receptor.

Authors:  D Wu; J Yang; W M Pardridge
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

3.  Cationic dyes reveal proteoglycans structurally integrated within the characteristic lesions of Alzheimer's disease.

Authors:  A D Snow; S Lara; D Nochlin; T N Wight
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

4.  Sporadic cerebral amyloid angiopathy with giant cell reaction.

Authors:  J M Powers; B M Stein; R A Torres
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

Review 5.  Alzheimer disease.

Authors:  Rudy J Castellani; Raj K Rolston; Mark A Smith
Journal:  Dis Mon       Date:  2010-09       Impact factor: 3.800

6.  Immunohistological study of senile brains by using a monoclonal antibody recognizing beta amyloid precursor protein: significance of granular deposits in relation with senile plaques.

Authors:  H Takahashi; C Kurashima; M Utsuyama; K Hirokawa
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

7.  Vector-mediated delivery of 125I-labeled beta-amyloid peptide A beta 1-40 through the blood-brain barrier and binding to Alzheimer disease amyloid of the A beta 1-40/vector complex.

Authors:  Y Saito; J Buciak; J Yang; W M Pardridge
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

8.  Immunohistochemical study of cerebral amyloid angiopathy. II. Enhancement of immunostaining using formic acid pretreatment of tissue sections.

Authors:  H V Vinters; W M Pardridge; D L Secor; N Ishii
Journal:  Am J Pathol       Date:  1988-10       Impact factor: 4.307

9.  The effect of age on protein composition of rat cerebral microvessels.

Authors:  A D Mooradian; K E Meredith
Journal:  Neurochem Res       Date:  1992-07       Impact factor: 3.996

10.  Isolation and biochemical characterization of amyloid plaques and paired helical filaments.

Authors:  Agueda Rostagno; Jorge Ghiso
Journal:  Curr Protoc Cell Biol       Date:  2009-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.